Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Síndrome de Kearns-Sayre
Total 0 results
Nothing found
Sponsors and Collaborators
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
iCAD
Neurophth Therapeutics Inc
Kupfer, David J., M.D.
RMIT University, Melbourne, Australia
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Hospital Durand, Argentina
Hospital ASEPEYO Sant Cugat
Alma Lasers Inc.
Mª Victoria Maestre Sanchez
GFI
Nacuity Pharmaceuticals, Inc.
Aptis Medical
Agency for Science, Technology and Research
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Korean Society of Spine Surgery
ASST Cremona, Cremona
Apollo Neuroscience, Inc.
Eurofins Genoma
Everett Meyer
View Full List
Medical Conditions
Age-related Hearing Loss
Post Covid-19 Condition
Optimys Femoral Stem
Hospital Acquired Pressure Ulcer
Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use
Renal Function Disorder
PD-1 Refractory Advanced Melanoma
Accuracy and Precision of Noninvasive Measurement
Anaplastic Large-cell Lymphoma
Surgical Patient
Dislocation, Shoulder
Sporadic
Neck Mass
Anatomic Stage 2A Breast Cancer AJCC v8
LOW OVARIAN RESPONSE
Extraarticular Fracture
STEMI - ST-segment Elevation Myocardial Infarction
Social Anxiety
Decay
Artificial Pancreas
View Full List
Drug Interventions
Olopatadine
Letrozole
Desvenlafaxine
Capecitabine/cisplatin
PD-1/PD-L1 inhibitor
THC
Fospropofol disodium, propofol
Standard of care (SOC) for COVID-19
RDX227675
MLN2480
Intravenous Formulation of PD-0332991
GLPG1837 multiple ascending doses
Midazolam
Oxycodone/acetaminophen 5/325 mg
Camptosar
Intravenous deferiprone
Capecitabine and IMRT (if randomized to this arm)
Anticholinergic
TPN-101
OnabotulinumtoxinA
View Full List
CROs by country
Contract Research Organizations in Bahrain
Contract Research Organizations in Burundi
Contract Research Organizations in Colombia
Contract Research Organizations in Croatia
Contract Research Organizations in Ecuador
Contract Research Organizations in El Salvador
Contract Research Organizations in Kenya
Contract Research Organizations in Kuwait
Contract Research Organizations in Macedonia
Contract Research Organizations in Mauritania
Contract Research Organizations in Mauritius
Contract Research Organizations in Rwanda
Contract Research Organizations in Suriname
CRO list by country
CROs in Uzbekistan
PASPIGIONI
SGS
All CROs in Uzbekistan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe